Skip to main content
Cureus logoLink to Cureus
. 2022 Jun 6;14(6):e25681. doi: 10.7759/cureus.25681

Bile Collected From the Normal Gallbladder of Patients During Surgery Has Simple Bacterial Flora

Shin Watanabe 1,, Masaaki Minagawa 2, Tadashi Shinoda 3, Daisuke Motooka 4, Mari Tohya 1, Teruo Kirikae 1, Shota Nakamura 4, Akio Saiura 2
Editors: Alexander Muacevic, John R Adler
PMCID: PMC9257430  PMID: 35812645

Abstract

Background

Bile inhibits bacterial growth because it is rich in bacteriostatic compounds such as bile acids. Analytical techniques using a high-intensity sequencer recently revealed bacterial flora in the bile of normal gallbladders in brain-dead patients. Therefore, we performed a microbial flora analysis of bile collected from pathologically normal gallbladders surgically removed from patients with hepatobiliary pancreatic diseases and normal liver function.

Methods

Bacterial DNA was extracted from bile samples and analyzed using 16S rRNA sequencing.

Results

The culture results of all 12 bile samples were negative. However, the results of the 16S ribosome gene analysis suggested the presence of bacterial flora in all samples. The phyla Firmicutes, ProteobacteriaActinobacteria, and, more specifically, the genera Anaerobacillus, Delftia, Bacillus, Ralstonia, Ochrobactrum, Acidovorax, and Curvibacter were detected in all 12 samples. The results of the 16S rRNA gene profile analysis revealed that Anaerobacillus and Delftia accounted for 58.62%-87.63% of the bacteria identified in each sample.

Conclusion

In a bacterial flora analysis targeting the 16S ribosomal gene, a specific bacterial flora was detected in bile collected from the pathologically normal gallbladders of patients with hepatobiliary pancreatic diseases. Although a diverse bacterial flora was previously reported in the bile of brain-dead patients, the present results revealed a simple bacterial flora with no diversity in the bile samples.

Keywords: human, rrna genes, microbiome, bile, gallbladder

Introduction

Newly developed, high-efficient gene analysis technology has contributed to advances in bacterial microbiome research targeting intestinal bacteria, its relationship with various diseases, and their etiologies [1-2]. Difficulties are associated with examining the functional role of bacteria using a 16S rRNA gene analysis alone; however, this new technology facilitates the identification of bacterial species that are challenging to detect using normal culture techniques, as they require only a small bacterial sample.

The bacterial flora within an organ has been implicated in the pathology of disease [3-4]. Bile in the gallbladder was previously considered to be sterile in healthy patients because it does not provide a suitable environment for the survival and growth of bacteria [5]. However, a recent study reported a diverse bacterial flora in the gallbladder bile of seemingly healthy individuals [6]. The presence of a small amount of a unique bacterial flora in bile that is difficult to culture with normal methods has been suggested to inhibit the invasion of other pathogenic bacteria [6].

Genetic analysis of healthy porcine gallbladder bile recently revealed specific bacteria in gallbladder bile [7]. Age-related changes in the bile microbiome of rabbits have also been reported [8]. However, the bile of healthy humans cannot be sampled for ethical reasons. Due to the high detection sensitivity of genetic analyses, DNA sample contamination always exists. Furthermore, the test procedure may be a risk factor for biliary tract infection, even when a bacterial flora analysis is conducted via endoscopic retrograde cholangiopancreatography (ERCP), during which bile collection is possible [9-11]. Until recently, the bacterial flora of bile in healthy gallbladders had not been analyzed for ethical reasons. Molinero et al. aseptically collected and examined bile from the gallbladders of brain-dead patients with abnormalities in the biliary system and detected bacteria at the genetic level [12]. However, since these patients were likely to have had an underlying disease, the continual presence of specific bacteria in the normal gallbladder of healthy individuals cannot be assumed. Therefore, in the present study, bile was collected from patients with a very low risk of biliary tract infection and subjected to a 16S ribosomal gene analysis to confirm the presence of a microbiome.

This article was previously posted to the Research Square preprint server on September 15, 2021.

Materials and methods

Patients

Bile samples were collected from the gallbladders of 12 patients (nine men and three women; age range, 43-89 years) who underwent hepatobiliary and pancreatic surgeries for malignant or non-malignant causes between August 2018 and May 2019 at Juntendo University Hospital (Tokyo, Japan) and required simultaneous cholecystectomy for procedural reasons. The gallbladders included in this study were macroscopically free of inflammation and infection, and bile samples were collected aseptically during surgery by a hepatobiliary and pancreatic surgeon (Table 1).

Table 1. Clinical characteristics and biochemical data of the study subjects.

WBC: white blood cell count, CRP: C-reactive protein, T-bil: total bilirubin, γ-GTP: γ-glutamyl transpeptidase, AST: aspartate aminotransferase, ALT: alanine aminotransferase, CA19-9: carbohydrate antigen 19-9

Patient No. Sex Age Disease Surgical procedure WBC CRP T-bil Γ-GTP AST ALT Lipase CA19-9
reference ranges for blood tests
M: 3.9-9.7 ×109/L F: 3.6-8.9 ×109/L <0.30 mg/dL 0.4-1.2 mg/dL 0-75 U/L 5-37 U/L 6-43 U/L 14-56 U/L <37 U/mL
1 Male 70 hepatocellular carcinoma hepatectomy of segments 5 and 6 6.3 0.08 0.63 27 39 41 61 1
2 Female 69 pancreatic neuroendocrine tumor pancreatoduodenectomy 6.0 0.29 1.62 23 16 13 33 6
3 Female 44 solid-pseudopapillary neoplasm pancreatoduodenectomy 7.8 0.04 0.47 13 20 15 37 5
4 Male 71 pancreatic head cancer pancreatoduodenectomy 4.7 2.48 0.42 15 25 21 255 10
5 Male 63 pancreatic body cancer resection of the pancreatic body and tail 4.2 0.05 0.6 20 16 15 45 1712
6 Male 48 gastrointestinal stromal tumor partial duodenectomy 3.9 0.04 2.1 61 30 26 49 4
7 Male 84 metastatic liver cancer hepatectomy of segments 4 and 5 5.1 0.05 0.7 13 16 13 NA 8
8 Male 70 pancreatic body cancer resection of the pancreatic body and tail 3.7 0.17 0.58 50 35 37 121 8
9 Male 70 pancreatic neuroendocrine tumor pancreatoduodenectomy 5.5 0.05 0.61 15 20 14 30 24
10 Female 89 hepatocellular carcinoma enucleation of the liver 7.5 0.34 0.5 23 18 11 21 6
11 Male 43 pancreatic body cancer pancreatoduodenectomy 5.6 0.02 1.16 30 26 43 12 19
12 Male 68 hepatocellular carcinoma hepatic anterior segmentectomy 3.1 0.03 0.39 56 24 17 70 NA

Bile was withdrawn from the fundus of the gallbladder using an 18G needle. The specimens collected were immediately divided into 2 cc sterile testing tubes and stored at -80°C for later analyses. Bile samples were aerobically cultured with blood agar/bromothymol blue agar and anaerobically cultured with phenethyl alcohol/Bacteroides bile esculin agar medium immediately in the in-hospital laboratory. All patients received an infusion of 2 g cefmetazole one to two hours before cholecystectomy. The gallbladder was included in the analysis only for those cases in which the gallbladder was diagnosed as normal with no abnormal pathological findings by a pathologist in the hospital after surgery.

Patients who had no gallstones, a pathologically normal gallbladder, no hepatobiliary enzyme abnormalities, no inflammatory markers, and had not undergone ERCP or biliary drainage or received antibiotics three months before the present study were considered to have a healthy gallbladder and were included in analyses.

All patients provided informed consent before the procedure. The present study was approved by the Juntendo University Hospital Ethics Committee (approval number: JHS18-0309) and was conducted according to the principles of the Declaration of Helsinki.

DNA isolation

Bacterial DNA was extracted from bile samples using the DNeasy PowerSoil Kit (QIAGEN, Venlo, the Netherlands). Specimens were stored under the same conditions and were processed by trained staff using identical protocols. Samples were collected using sterile techniques for quality control. Polymerase chain reaction (PCR) reagents were regularly checked for environmental contaminants. PCR reactions had appropriate controls (without a template) to exclude DNA contaminants. To control the quality of sequencing, we used a ‘negative’ (reagent-only) control and checked for background contamination and the rate of sequencing errors.

Preparation of the 16S rRNA gene sequencing library

A library was created for each specimen using a primer set (27Fmod: 5ʹ AGR GTT TGA TCM TGG CTC AG 3ʹ and 338R: 5ʹ TGC TGC CTC CCG TAG GAG T 3ʹ) targeting the V1-V2 region of the 16S ribosomal gene based on the guidelines of the Illumina 16S Metagenomic Sequencing Library Preparation Guide [13]. MiSeq (Illumina, Inc., San Diego, CA) was used to perform a 251-base pair (bp) pair-end sequencing of this amplicon.

Sequence processing

The 251-bp paired-end sequence obtained from each specimen was processed using QIIME2 (version 2021.4; https://docs.qiime2.org/2021.4/data-resources/#silva-16s-18s-rrna) [14]. The Illumina MiSeq pair-end sequence (Fastq format) was demultiplexed (demux) to QIIME2. The DADA2 plugin was then used to trim the ends for an average quality score ≥37, and low-quality sequences and chimeric sequences were removed [15]. Therefore, the sequences obtained from each specimen had a minimum number of reads of 68,185, a maximum number of reads of 165,362, and an average number of reads of 102,623. Each sequence was then subjected to MAFFT multiple sequence alignment. Positional conservation and gap filtering were conducted using the mask plugin.

Sequence analysis

A phylogenetic tree was created using the FastTree plugin and midpoint-root plugin. Silva-138-99 sequences were obtained from the QIIME 2 website, and a dataset of sequence data spliced from the region bracketed by the 27Fmod and 338R primers and operational taxonomic units was created [13]. Class names in this dataset were extrapolated from sequence data obtained from samples as classifiers in the QIIME2 q2-feature-classifier plugin. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Results

Bacterial growth was not detected in aerobic or anaerobic cultures of any of the 12 bile specimens collected. However, the phyla Firmicutes, Proteobacteria, and Actinobacteria were found in all specimens during the 16S ribosomal gene analysis and accounted for more than 80% of the flora detected. The phylum Fusobacteria was identified in 3/12 specimens (Figure 1).

Figure 1. 16S ribosomal gene analysis (phylum).

Figure 1

Within the phylum Firmicutes, the genera Anaerobacillus (33.41 ± 7.0441% of the flora detected), and Bacillus (6.623 ± 3.8955% of the flora detected) were present in all specimens based on the 16S rRNA gene profile analysis. All bile samples contained the following genera in the phylum Proteobacteria: Delftia (18.68 ± 4.3935% of the flora detected), Ralstonia (4.14 ± 6.1401% of the flora detected), Ochrobactrum (4.518 ± 2.3837% of the flora detected), Acidovorax (3.016 ± 1.943% of the flora detected), and Curvibacter (1.561 ± 1.0242% of the flora detected). No bacteria of the phylum Actinobacteria were identified in any sample. Based on the 16S rRNA gene profile analysis, bacteria in the genera Anaerobacillus and Delftia accounted for 42.53-64.63% of the flora detected in each specimen (Figure 2).

Figure 2. 16S ribosomal gene analysis (genus).

Figure 2

Discussion

​​​​​​The present results revealed simple bacterial flora with no diversity in gallbladder bile. The functional significance of the bacterial flora identified in this study remains unclear.

Bile acids exhibit antibacterial activities that dissolve bacterial membranes and damage bacterial DNA; therefore, bile in the biliary tract was previously considered to be sterile in healthy individuals [16]. However, some bacteria, such as Salmonella spp. and Listeria monocytogenes, may survive in the gallbladder and have been implicated in infections and the development of gallstones [17-18].

A bacterial flora analysis, based on gene sequencing using a high-efficiency sequencer, recently provided a new perspective in the field of microbiology. Flora that cannot be identified using conventional morphological cultures may be detected using gene sequencing, thereby allowing for flora classification. Bacterial genome analysis of bile in a gallbladder without inflammation, which is considered to be a low biomass environment, should be carefully evaluated with attention to the method of collection, preservation, and environment of DNA extraction of bile samples. The characteristics of the PCR kit itself always need to be considered. Recent studies reported the presence of bacteria in the gallbladder bile of relatively healthy individuals. Gene sequencing has been used to detect bacteria in the gallbladder bile of healthy swine and rabbits [7-8]. However, the bile of healthy humans cannot be sampled for ethical reasons, and the collection of bile using an endoscope is limited by contamination. Furthermore, the gallbladder of a healthy human cannot be excised for a pathological examination. To overcome these limitations, Molinero et al. performed gene sequencing on bile collected from the gallbladders of brain-dead patients and identified a bacterial flora that was not detected using conventional bacterial cultures [12]. The bacterial flora of bile in patients with cholelithiasis was also examined in that study, and the findings obtained revealed differences from that in patients with healthy gallbladders. However, the medical histories of brain-dead patients were diverse, and a pathological examination of the gallbladder and detailed liver function tests are typically not performed on these patients. In the present study, bile samples were collected from patients with normal liver function and a pathologically normal gallbladder who did not receive any antibiotics or undergo any procedures that may have affected the biliary system prior to the initiation of the study. However, most of the patients examined had cancer, which may have affected the results obtained. Although these patients had no medical history suggestive of inflammation and no bias toward a specific disease, they all had pancreaticobiliary diseases. Therefore, based on laboratory data, we considered the likelihood of infected bile in the gallbladder to be low. In the present study, a microbiome was identified in all bile samples using 16S rRNA gene sequencing.

The composition of the bacterial flora in bile in the present study was less diverse than that reported by Molinero et al. who reported that the phylum Bacteroidetes accounted for 30% of the phyla detected [12]. In the present study, the phyla Firmicutes and Proteobacteria accounted for 80% of the flora detected, the diversity of which was low.@@

At the genus level, Anaerobacillus and Delftia accounted for most of the bacteria in each specimen. Molinero et al. detected bacteria predominantly from the genera Lactococcus, Propionibacterium, Bifidobacterium, and Bradyrhizobium, which differs from the present results. These differences may be attributed to the methodologies used, with the QIIME system being employed in the previous study and the QIIME2 system in the present study. Furthermore, a previous study demonstrated that an examination of intestinal bacteria in the V1-2 region rather than in the V3-4 region is more suitable for Japanese individuals [19]. Therefore, we investigated the V1-2 region as bile is affected by the bacterial flora of the gastrointestinal tract.

The biliary tract of a healthy person was previously considered to be a sterile environment based on established culture tests. Although we collected samples from surgical patients, our findings from sequencing indicate the presence of flora specific to the gallbladder bile. This suggests that the bacteria may have entered the gallbladder in a retrograde manner from the duodenum or portal vein. When the duodenal papilla functions normally, duodenal fluid (including bacteria) does not enter the bile duct. A previous study reported that distal cholangiocarcinoma may impair the function of the duodenal papilla, leading to the accumulation of bile in the bile duct [18]; however, papillary dysfunction was not observed in the present study. Bile is constantly produced and excreted into the duodenum when food is consumed. Therefore, the presence of duodenal bacteria in gallbladder bile is only expected under pathological conditions such as biliary obstruction. As another hypothesis, if bacteria survive in bile through portal veins from the intestines, the differences observed between the present results and the findings of Molinero et al. [12] are consistent with a previous study showing a unique intestinal flora in Japanese patients, which differed from those of Chinese and Western patients [20].

The present study was performed to establish whether bacterial flora is present in bile in the normal gallbladder. Of note, the subjects were not truly healthy and, additionally, the sample size was limited by strict criteria, i.e., including only those who had not undergone ERCP with normal data of the hepatobiliary system. Furthermore, biases affecting the analysis of low biomass samples, such as variable regions set during genome analysis and different analysis software, could not be eliminated and only Japanese patients were included. These factors may have limited the results of the study.

Further studies involving functional and quantitative evaluations of the bacterial flora present in the gallbladder are warranted.

Conclusions

The results of the 16S rRNA gene profile analysis revealed that Anaerobacillus and Delftia accounted for 58.62-87.63% of the bacteria identified in each sample of bile in the gallbladder. Our findings indicate the presence of bile-specific bacteria in the normal gallbladder. Thus, future studies are needed to fully elucidate the role of these bacteria.

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

Funding Statement

This work was supported by Asahi Group Holdings, Ltd. (Tokyo, Japan) The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

The authors have declared financial relationships, which are detailed in the next section.

Tadashi Shinoda declare(s) employment from Asahi Group Holdings, Ltd. TS is an employee of Asahi Quality & Innovations. Ltd. All other authors declare that they have no competing interests.

Human Ethics

Consent was obtained or waived by all participants in this study. Research Ethics Committee, Faculty of Medicine, Juntendo University issued approval JHS 18-0309. All experimental procedures used in the present study complied with the ethical standards of the national guidelines of the Japanese government on human experimentation and the Declaration of Helsinki. The present study was approved by Research Ethics Committee, Faculty of Medicine, Juntendo University (approval number: JHS 18-0309), and written informed consent was obtained from all patients

Animal Ethics

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

References

  • 1.An obesity-associated gut microbiome with increased capacity for energy harvest. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. Nature. 2006;444:1027–1031. doi: 10.1038/nature05414. [DOI] [PubMed] [Google Scholar]
  • 2.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Wang Z, Klipfell E, Bennett BJ, et al. Nature. 2011;472:57–63. doi: 10.1038/nature09922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Riquelme E, Zhang Y, Zhang L, et al. https://pubmed.ncbi.nlm.nih.gov/31398337/ Cell. 2019;178:795–806. doi: 10.1016/j.cell.2019.07.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.The human milk microbiota: origin and potential roles in health and disease. Fernández L, Langa S, Martín V, Maldonado A, Jiménez E, Martín R, Rodríguez JM. Pharmacol Res. 2013;69:1–10. doi: 10.1016/j.phrs.2012.09.001. [DOI] [PubMed] [Google Scholar]
  • 5.Effect of bile salts on the DNA and membrane integrity of enteric bacteria. Merritt ME, Donaldson JR. J Med Microbiol. 2009;58:1533–1541. doi: 10.1099/jmm.0.014092-0. [DOI] [PubMed] [Google Scholar]
  • 6.Chronic and acute infection of the gall bladder by Salmonella typhi: understanding the carrier state. Gonzalez-Escobedo G, Marshall JM, Gunn JS. Nat Rev Microbiol. 2011;9:9–14. doi: 10.1038/nrmicro2490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Characterization of the bile and gall bladder microbiota of healthy pigs. Jiménez E, Sánchez B, Farina A, Margolles A, Rodríguez JM. Microbiologyopen. 2014;3:937–949. doi: 10.1002/mbo3.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Dynamic distribution of gallbladder microbiota in rabbit at different ages and health states. Xing Y, Liu J, Lu F, Wang L, Li Y, Ouyang C. PLoS One. 2019;14:0. doi: 10.1371/journal.pone.0211828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rate and impact of duodenoscope contamination: a systematic review and meta-analysis. Larsen S, Russell RV, Ockert LK, Spanos S, Travis HS, Ehlers LH, Mærkedahl A. EClinicalMedicine. 2020;25:100451. doi: 10.1016/j.eclinm.2020.100451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Infection using ERCP endoscopes. Petersen BT, Koch J, Ginsberg GG. Gastroenterology. 2016;151:46–50. doi: 10.1053/j.gastro.2016.05.040. [DOI] [PubMed] [Google Scholar]
  • 11.Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. Salter SJ, Cox MJ, Turek EM, et al. BMC Biol. 2014;12:87. doi: 10.1186/s12915-014-0087-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile. Molinero N, Ruiz L, Milani C, et al. Microbiome. 2019;7:100. doi: 10.1186/s40168-019-0712-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. Kim SW, Suda W, Kim S, et al. DNA Res. 2013;20:241–253. doi: 10.1093/dnares/dst006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Bolyen E, Rideout JR, Dillon MR, et al. Nat Biotechnol. 2019;37:852–857. doi: 10.1038/s41587-019-0209-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.DADA2: high-resolution sample inference from Illumina amplicon data. Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. Nat Methods. 2016;13:581–583. doi: 10.1038/nmeth.3869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.The interaction between bacteria and bile. Begley M, Gahan CG, Hill C. FEMS Microbiol Rev. 2005;29:625–651. doi: 10.1016/j.femsre.2004.09.003. [DOI] [PubMed] [Google Scholar]
  • 17.Gallstones play a significant role in Salmonella spp. gallbladder colonization and carriage. Crawford RW, Rosales-Reyes R, Ramírez-Aguilar Mde L, Chapa-Azuela O, Alpuche-Aranda C, Gunn JS. Proc Natl Acad Sci U S A. 2010;107:4353–4358. doi: 10.1073/pnas.1000862107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Extracellular replication of Listeria monocytogenes in the murine gall bladder. Hardy J, Francis KP, DeBoer M, Chu P, Gibbs K, Contag CH. Science. 2004;303:851–853. doi: 10.1126/science.1092712. [DOI] [PubMed] [Google Scholar]
  • 19.Benchmark of 16S rRNA gene amplicon sequencing using Japanese gut microbiome data from the V1-V2 and V3-V4 primer sets. Kameoka S, Motooka D, Watanabe S, et al. BMC Genomics. 2021;22:527. doi: 10.1186/s12864-021-07746-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.The gut microbiome of healthy Japanese and its microbial and functional uniqueness. Nishijima S, Suda W, Oshima K, Kim SW, Hirose Y, Morita H, Hattori M. DNA Res. 2016;23:125–133. doi: 10.1093/dnares/dsw002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES